Curis Lifesciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 146.10 on the Bombay Stock Exchange, a 14.14 per cent premium to its issue price of Rs 128.00. On the National Stock Exchange, the stock was listed at Rs 146.10.

The company, which raised 0.22 Cr from initial public offering, was subscribed 0 times, receiving bids for 0 lakhs shares against the total issue size of 21.50 lakhs shares.

The company, listed under ST Group Securities post its IPO, opened for subscription from Nov 07 to Nov 11.

Following a strong opening, the scrip touched an intraday high of Rs [BSEHighPrice] and a low of Rs [NSEHighPrice], before closing the session [UpDown] by [ChangePer] per cent to its listing price at Rs [ClosingPriceBSE] on the NSE.

The company anticipates using the proceeds of the issue for .

Finaax Capital Advisors Pvt. Ltd. as lead managers & MUFG Intime India Pvt. Ltd. is the registrar, to the issue.

Meanwhile, the broader benchmark NSE Nifty closed trade at 25,879.15, up 3.35 points, or 0.01 per cent.